Christopher J. Stubbs

1.1k total citations
33 papers, 785 citations indexed

About

Christopher J. Stubbs is a scholar working on Molecular Biology, Cell Biology and Pharmacology. According to data from OpenAlex, Christopher J. Stubbs has authored 33 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Pharmacology. Recurrent topics in Christopher J. Stubbs's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Microtubule and mitosis dynamics (6 papers) and Protein Structure and Dynamics (5 papers). Christopher J. Stubbs is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Microtubule and mitosis dynamics (6 papers) and Protein Structure and Dynamics (5 papers). Christopher J. Stubbs collaborates with scholars based in United Kingdom, South Africa and Germany. Christopher J. Stubbs's co-authors include Isadore Kanfer, Chris Abell, Steffen Lang, P. Sledz, J.M. Haigh, David R. Spring, Ashok R. Venkitaraman, Marko Hyvönen, Christopher Phillips and Robert B. Best and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Biochemistry.

In The Last Decade

Christopher J. Stubbs

32 papers receiving 772 citations

Peers

Christopher J. Stubbs
Ana Negri Spain
J. Rotonda United States
Kenneth M. Comess United States
Jaimeen D. Majmudar United States
Donna Carr United States
Arwin Aban United States
Christopher J. Stubbs
Citations per year, relative to Christopher J. Stubbs Christopher J. Stubbs (= 1×) peers Manuela Gridling

Countries citing papers authored by Christopher J. Stubbs

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Stubbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Stubbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Stubbs more than expected).

Fields of papers citing papers by Christopher J. Stubbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Stubbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Stubbs. The network helps show where Christopher J. Stubbs may publish in the future.

Co-authorship network of co-authors of Christopher J. Stubbs

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Stubbs. A scholar is included among the top collaborators of Christopher J. Stubbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Stubbs. Christopher J. Stubbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stubbs, Christopher J., Marianne Schimpl, Thomas Tischer, et al.. (2025). Development of D-box peptides to inhibit the anaphase-promoting complex/cyclosome. eLife. 14.
2.
Sala, Giuseppina La, Christopher Pfleger, Helena Käck, et al.. (2023). Combining structural and coevolution information to unveil allosteric sites. Chemical Science. 14(25). 7057–7067. 13 indexed citations
3.
MacDonald, Jessica L., Jennifer Ward, Christopher J. Stubbs, et al.. (2023). Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function. Chemical Science. 14(26). 7136–7146. 8 indexed citations
4.
Collie, Gavin W., Ulf Börjesson, Ian L. Dale, et al.. (2022). Discovery of a selective c-MET inhibitor with a novel binding mode. Bioorganic & Medicinal Chemistry Letters. 75. 128948–128948. 9 indexed citations
5.
Malvezzi, Francesca, Christopher J. Stubbs, Thomas A. Jowitt, et al.. (2021). Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins. Communications Biology. 4(1). 1273–1273. 14 indexed citations
6.
Collie, Gavin W., Iacovos N. Michaelides, Kevin J. Embrey, et al.. (2020). Structural Basis for Targeting the Folded P-Loop Conformation of c-MET. ACS Medicinal Chemistry Letters. 12(1). 162–167. 15 indexed citations
7.
Liu, Yang, Tom D. Bunney, Kevin Macé, et al.. (2020). Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes. EBioMedicine. 51. 102607–102607. 27 indexed citations
8.
Gunnarsson, Anders, Christopher J. Stubbs, Philip B. Rawlins, et al.. (2020). Regenerable Biosensors for Small-Molecule Kinetic Characterization Using SPR. SLAS DISCOVERY. 26(5). 730–739. 13 indexed citations
9.
Collie, Gavin W., Cheryl M. Koh, Daniel O’Neill, et al.. (2019). Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors. ACS Medicinal Chemistry Letters. 10(9). 1322–1327. 39 indexed citations
10.
Dix, Carly I., Christopher J. Stubbs, Eileen McCall, et al.. (2019). Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies. Modern Pathology. 33(4). 518–530. 58 indexed citations
11.
Batt, Sarah M., Christopher J. Stubbs, Esther Pérez‐Herrán, et al.. (2015). Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase. ACS Infectious Diseases. 1(12). 615–626. 48 indexed citations
12.
Tan, Yaw Sing, P. Sledz, Steffen Lang, et al.. (2012). Using Ligand‐Mapping Simulations to Design a Ligand Selectively Targeting a Cryptic Surface Pocket of Polo‐Like Kinase 1. Angewandte Chemie. 124(40). 10225–10228. 6 indexed citations
13.
Tan, Yaw Sing, P. Sledz, Steffen Lang, et al.. (2012). Using Ligand‐Mapping Simulations to Design a Ligand Selectively Targeting a Cryptic Surface Pocket of Polo‐Like Kinase 1. Angewandte Chemie International Edition. 51(40). 10078–10081. 65 indexed citations
14.
Sledz, P., Steffen Lang, Christopher J. Stubbs, & Chris Abell. (2012). High‐Throughput Interrogation of Ligand Binding Mode Using a Fluorescence‐Based Assay. Angewandte Chemie. 124(31). 7800–7803. 11 indexed citations
15.
Sledz, P., Steffen Lang, Christopher J. Stubbs, & Chris Abell. (2012). High‐Throughput Interrogation of Ligand Binding Mode Using a Fluorescence‐Based Assay. Angewandte Chemie International Edition. 51(31). 7680–7683. 30 indexed citations
16.
Sledz, P., Christopher J. Stubbs, Steffen Lang, et al.. (2011). From Crystal Packing to Molecular Recognition: Prediction and Discovery of a Binding Site on the Surface of Polo‐Like Kinase 1. Angewandte Chemie International Edition. 50(17). 4003–4006. 61 indexed citations
17.
Sledz, P., Christopher J. Stubbs, Steffen Lang, et al.. (2011). From Crystal Packing to Molecular Recognition: Prediction and Discovery of a Binding Site on the Surface of Polo‐Like Kinase 1. Angewandte Chemie. 123(17). 4089–4092. 8 indexed citations
18.
Stubbs, Christopher J. & Isadore Kanfer. (1989). Variability in the Absorption and Disposition of Erythromycin Estolate in Humans. Journal of Pharmaceutical Sciences. 78(8). 635–638. 2 indexed citations
19.
Stubbs, Christopher J. & Isadore Kanfer. (1988). High-performance liquid chromatography of erythromycin propionyl ester and erythromycin base in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 427(1). 93–101. 30 indexed citations
20.
Stubbs, Christopher J., J.M. Haigh, & Isadore Kanfer. (1986). High-performance liquid chromatographic analysis of oleandomycin in serum and urine. Journal of Chromatography A. 353. 33–37. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026